Purchase Order N0017320P0507
- Not listed
- The Office of Naval Research awarded a $3,300 firm fixed-price purchase order to Weill Medical College of Cornell University for genomic DNA sequence service. The contract was awarded on June 7, 2013, with an ultimate completion date of August 6, 2013, and was performed in New York, New York. No set-aside designation was used in this award, indicating full and open competition. Weill Medical College, a division of Cornell University, is a leading academic medical institution with substantial...
- The Office of Naval Research awarded a $61.5K firm fixed-price purchase order to Weill Medical College of Cornell University for DNA samples service (PR# 69-4332-19) with an ultimate completion date of January 28, 2020. The contract was not set aside for any specific category and was awarded on September 30, 2019, following a special notice solicitation posted on July 30, 2019. Work will be performed in New York, New York. Weill Medical College, a child entity of Cornell University, is a leading...
- Weill Medical College of Cornell University received a $3,100 firm fixed-price purchase order for sequencing services, awarded on December 19, 2016, with an ultimate completion date of the same day. The contract, which was not set aside for any specific category, was funded by a civilian agency within the Southeast Area and performed in New York, NY. As a child entity of Cornell University, Weill Medical College leveraged its established capabilities in biomedical research and scientific...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to Weill Medical College of Cornell University, a private non-profit university. The contract is for "Transcriptome Analysis and Gene Expression Studies with Next Gen Illumina/Solex A HiSeq Sequencing Service", with a ceiling value of $20,500.00 and a completion date of September 30, 2016. The award was made on March 8, 2012 and there is no set-aside designation. Weill Medical College of Cornell University...
- Weill Medical College of Cornell University was awarded a $14,060 firm fixed-price purchase order on August 30, 2018, for DNA sequencing services utilizing the Illumina HiSeq4000 sequencing platform. The contract, with an ultimate completion date of September 28, 2018, was funded by the USDA Agricultural Research Service (ARS) Robert W. Holley Center in Ithaca, New York, where the sequencing samples were to be shipped and processed under the direction of Dr. Yimin Xu. No set-aside designation...
- This is a federal contract award to Weill Medical College of Cornell University, a prestigious academic medical institution in New York City. The contract, awarded by the Department of the Navy, is a Firm Fixed Price Delivery Order with a ceiling value of $42,374.00. The contract does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by Weill Medical College with the National Cancer Institute, valued at...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Weill Medical College of Cornell University, a private research university, for whole genomic sequencing services. The contract, valued at $138,700.00, is for the Sequencing Quality Control (SeQC2) study, which involves sample processing, library construction, sequencing, and data analysis. The work will be performed by Weill Medical College and its subcontractor, Hudsonalpha Institute for...
- This federal contract award was issued by the Food and Drug Administration (FDA) to Weill Medical College of Cornell University, a private research university, for the sequencing of genomic DNA. The contract has a ceiling value of $268,000.00 and was awarded on May 23, 2016 with a completion date of December 30, 2016. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The contract is part of the FDA's broader "SEQUENCE GENOMIC DNA" program,...
- This federal contract award was issued by a civilian U.S. government agency to Cornell University for genomics research and services. The contract has a ceiling value of $30,310.00 and utilizes a firm-fixed-price pricing type. It includes the purchase of an Illumina NextSeq500 sequencing system and RNA sequencing library construction services for the Cornell University Genomics Facility. The contract does not have a set-aside designation, indicating Cornell's broad capabilities to compete for...
- Cornell University's Office of Sponsored Programs received a $2,625 firm fixed-price contract award from a civilian Northeast Area federal agency on April 22, 2016, with an ultimate completion date of July 30, 2016. The contract, issued as a Blanket Purchase Agreement call, is for paired-end 2x150 base pair HiSeq rapid run DNA and RNA sequencing services utilizing Illumina HiSeq Genome Analyzer platform technology. The work is to be performed in Geneva, New York. No set-aside designation was...
The Office of Naval Research awarded a $52.78K firm fixed-price purchase order to Weill Medical College of Cornell University for NextGen Library Preparation & Sequencing services. The contract was issued on September 16, 2020, with an ultimate completion date of November 20, 2020, and will be performed in New York, NY. No set-aside designation was applied to this award, and the work relates to sequencing and library preparation activities likely supporting the institution's biomedical research capabilities. This purchase order represents a child contract under Weill Medical College's broader research portfolio with the Department of Defense. As a leading academic medical institution with extensive federal contracting experience, Weill Medical College regularly supports Department of the Navy research initiatives across multiple scientific domains. The contract's focus on NextGen sequencing services aligns with the college's established expertise in advanced research support, biomedical innovation, and translational science, which have made it a preferred partner for federal agencies pursuing cutting-edge medical research and development programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($17k) | 7/14/25 | |
| Not listed | Not listed | $52.8k | 9/21/20 |